Our latest news, insights & events
The first IPO of 2024 (and one of the few IPOs in the past year) was completed! Our corporate and
53 million NIS was raised in the Meitav Trade IPO
It was our pleasure to represent Sun Pharmaceutical Industries Limited (SUN.NS), in its acquisition of the minority interest in Taro
We represented Sun Pharma in the acquisition of the minority interest in Taro
On 18 January 2024 the legislature of New Hampshire passed the Act Relative to the Expectation of Privacy (the “Act”).
New Hampshire is the 14th US State to Adopt Comprehensive Privacy Legislation
The European Data Protection Board (EDPB) has issued a comprehensive report which focuses on the designation and position of Data
European Data Protection Regulatory Board Issues Investigative Report on the Role of Data Protection Officers
On 16 January 2024 the Governor of New Jersey signed into law the state’s Data Privacy Act (the “Act”), marking
New Jersey is the 13th US State to Adopt Comprehensive Privacy Legislation
Dear clients and friends, 1.We would like to inform you that on January 15, 2024, the government approved the state
The Government Has Approved a Mechanism for Taxation of Greenhouse Gas and Local Pollutants Emissions
Dear clients, We would like to inform you that the Israel Securities Authority (the “ISA”) has updated the conditions
An update to the Conditions of a General Permit under Section 49A to the Securities Law
Dear Clients, We are pleased to inform you that on January 11, 2024, the US Securities and Exchange Commission
New Opportunity for Global Fund Managers and Investors – the SEC Has Approved the Launch of Bitcoin Exchange-Traded Funds
Dear clients and colleagues, On January 15, 2024, the European Union Commission approved the recognition of the State of
Recognition of the State of Israel as a country with adequacy status in the field of privacy protection
Dear clients and friends, We would like to bring to your attention that the Israeli Securities Authority published proposed regulatory
Published: Proposed regulatory instructions regarding equity, insurance, or other collateral security
Congratulations to our client, Delinea, Inc., a leading provider of privileged access management, on completing the acquisition of the Israeli
